(Event Report)2nd Session of “Action on Health Technology” Series~Health Technology Implementation around the World: Learning from Netherlands~
date : 5/13/2016
For this 2nd session, we invited a leading expert on health technology from the Netherlands, Mr. Jeroen Tas, CEO of Connected Care and Health Informatics at Philips.
The Netherlands has overcome various regulatory bottlenecks and policy barriers to become one of the leading nations in the field of health technology including telemedicine and healthcare ICT. In this session, Mr. Tas has not only presented the latest technology in health care and the current situation of the Netherlands, but also provided an insight into the Netherlands’ experiences of policy making in this field from policy formulation and negotiation to implementation, evaluation and revision/adjustment. This session provided an opportunity for an open multi-stakeholder discussion for effective policy development with experts including private, public and academic sectors.
Opening Remarks
Prof. Hiroaki Miyata of Keio University addressed 4 critical areas in which health technology will bring significant impact to; “Cost Effectiveness”, “Specialty”, “Space” and “Time”. Health technology will improve cost effectiveness and shorten waiting time for laboratory examination. Integration of information by specialists on cloud platform and utilization of cloud data to identify best and personalized care for each patient will soon be possible by health technology.

Presentation(Mr. Jeroen Tas)
In the challenging time for healthcare history, the current healthcare system fails to adjust to the changing landscape with rise of chronic diseases, and financial resource constraints. Mr. Tas presented 4 key transitions healthcare must encounter; “Episodic to Continuous”, “Provider care to Patient centric”, “Fragmented to Connected”, and “Volume to Value”.

Describing it as “strange”, Mr. Tas elaborated particularity of healthcare and its obstacles, which can be overcome by use of technology. One critical point indicated was that healthcare is organized around providers while other industries are organized around consumers. He expressed further need of shift to “patient centric”. In addition, medical system needs to shift away from fee-for-service payment models and transform to be more preventive and cost effective. Having daughter with diabetes type 1, Mr. Tas promoted personalized care for each patient and his or her family.
In addition, Mr. Tas mentioned the current platform in the Netherlands by collaboration with the government and private sectors as a best practice of public private partnership for healthcare ICT.

After Mr. Tas’ presentation, he and experts from private, public and academic sectors had vibrant discussion and Q&A session to foster policy making in Japan.

Closing Remarks
Coucillor Michiyo Yakushiji closed the session, urging leadership of legislative body to overcome regulatory bottlenecks and facilitate building new technology from Japan.

The Netherlands has overcome various regulatory bottlenecks and policy barriers to become one of the leading nations in the field of health technology including telemedicine and healthcare ICT. In this session, Mr. Tas has not only presented the latest technology in health care and the current situation of the Netherlands, but also provided an insight into the Netherlands’ experiences of policy making in this field from policy formulation and negotiation to implementation, evaluation and revision/adjustment. This session provided an opportunity for an open multi-stakeholder discussion for effective policy development with experts including private, public and academic sectors.
Opening Remarks
Prof. Hiroaki Miyata of Keio University addressed 4 critical areas in which health technology will bring significant impact to; “Cost Effectiveness”, “Specialty”, “Space” and “Time”. Health technology will improve cost effectiveness and shorten waiting time for laboratory examination. Integration of information by specialists on cloud platform and utilization of cloud data to identify best and personalized care for each patient will soon be possible by health technology.
Presentation(Mr. Jeroen Tas)
In the challenging time for healthcare history, the current healthcare system fails to adjust to the changing landscape with rise of chronic diseases, and financial resource constraints. Mr. Tas presented 4 key transitions healthcare must encounter; “Episodic to Continuous”, “Provider care to Patient centric”, “Fragmented to Connected”, and “Volume to Value”.
Describing it as “strange”, Mr. Tas elaborated particularity of healthcare and its obstacles, which can be overcome by use of technology. One critical point indicated was that healthcare is organized around providers while other industries are organized around consumers. He expressed further need of shift to “patient centric”. In addition, medical system needs to shift away from fee-for-service payment models and transform to be more preventive and cost effective. Having daughter with diabetes type 1, Mr. Tas promoted personalized care for each patient and his or her family.
In addition, Mr. Tas mentioned the current platform in the Netherlands by collaboration with the government and private sectors as a best practice of public private partnership for healthcare ICT.
After Mr. Tas’ presentation, he and experts from private, public and academic sectors had vibrant discussion and Q&A session to foster policy making in Japan.
Closing Remarks
Coucillor Michiyo Yakushiji closed the session, urging leadership of legislative body to overcome regulatory bottlenecks and facilitate building new technology from Japan.
Exhibition date:2016-04-27
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)



